Lv1
70 积分 2024-03-31 加入
Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors
5小时前
待确认
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma
2个月前
已完结
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies,
3个月前
已完结
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up
3个月前
已完结
STREPTOMYCIN for tuberculosis; an evaluation of its present usefulness
3个月前
已关闭
A generative model uses healthy and diseased image pairs for pixel-level chest X-ray pathology localization
3个月前
已完结
Lisocabtagene Maraleucel (liso-cel) Combined with Ibrutinib (ibr) for Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Primary Results from the Open-Label, Phase 1/2 Transcend CLL 004 Study
3个月前
已关闭
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies
4个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
5个月前
已完结
皖公网安备34019202002308
